<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="124707">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01479062</url>
  </required_header>
  <id_info>
    <org_study_id>1R44NR012617-01</org_study_id>
    <nct_id>NCT01479062</nct_id>
  </id_info>
  <brief_title>Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics</brief_title>
  <official_title>Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (ALIVE-PD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Berkeley Analytics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Palo Alto Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Berkeley Analytics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The trial will test whether the Alive multi-channel delivery health behavior program can
      positively affect weight and glucose level in pre-diabetics.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in body weight</measure>
    <time_frame>at 3 months, 6 months and one year</time_frame>
    <description>Mean weight loss and the proportion of subjects who achieve a 5% body weight loss at 3 and 6 months and maintain at 12 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in diabetes risk markers</measure>
    <time_frame>at 3 months, 6 months and one year</time_frame>
    <description>Change in blood glucose level and hemoglobin A1c (HbA1c) as measured in clinic at 3 and 6 months and maintain at 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in physical activity and dietary factors</measure>
    <time_frame>3 months and 12 months</time_frame>
    <description>Extent of change in physical activity and dietary factors as reported in questionnaires</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Pre-diabetes</condition>
  <condition>Diabetes</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>participation in Alive-PD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Alive-PD lifestyle intervention with multi-channel delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Alive-PD</intervention_name>
    <description>Weekly email/web goal-setting intervention to improve physical activity, diet and weight loss for pre-diabetics, with additional phone support</description>
    <arm_group_label>participation in Alive-PD</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Placebo Control</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least one measurement in past 2 yrs of fasting plasma glucose of 100-125 mg/dl or
             impaired glucose tolerance

          -  at least one measurement of body mass index (BMI) &gt;=27 in the past two years

          -  age 40-79

          -  no use of diabetes medications within the past two years

          -  member of Kaiser Permanente of Northern California (KPNC) for at least 2 years

          -  live in a 25 mile radius of the KPNC Research Clinic in Oakland, CA

        Exclusion Criteria:

          -  comorbidities that would contraindicate the gradual adoption of light/moderate
             physical activity, such as a recent cardiovascular event, severe chronic obstructive
             pulmonary disease, advanced arthritis, or poorly controlled hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gladys Block, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Berkeley Analytics, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Palo Alto Medical Foundation Research Institute</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Block G, Azar KM, Block TJ, Romanelli RJ, Carpenter H, Hopkins D, Palaniappan L, Block CH. A Fully Automated Diabetes Prevention Program, Alive-PD: Program Design and Randomized Controlled Trial Protocol. JMIR Res Protoc. 2015 Jan 21;4(1):e3. doi: 10.2196/resprot.4046.</citation>
    <PMID>25608692</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <lastchanged_date>February 5, 2015</lastchanged_date>
  <firstreceived_date>November 22, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Berkeley Analytics, Inc.</investigator_affiliation>
    <investigator_full_name>Gladys Block</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>behavior change</keyword>
  <keyword>pre-diabetes</keyword>
  <keyword>prevention</keyword>
  <keyword>diabetes prevention</keyword>
  <keyword>Hemoglobin A1c</keyword>
  <keyword>glucose</keyword>
  <keyword>physical activity</keyword>
  <keyword>nutrition</keyword>
  <keyword>email</keyword>
  <keyword>web</keyword>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
